Evaluate HACOR socre utility and efficacy in predicting NIV and/or CPAP failure in patients with COVID-19 associated respiratory failure. Propose adaptations to HACOR score based on the "state of art" of COVID-19
Evaluate HACOR socre utility and efficacy in predicting NIV and/or CPAP failure in patients with COVID-19 associated respiratory failure. Propose adaptations to HACOR score based on the "state of art" of COVID-19 - this adaptations may include radiologic aggravation and monitoring of CRF, ferritin, LDH, d-dimers, NT-proBNP, troponin I, GOT, GPT, blood count
Other: Monitoring for aggravation
Monitor patients on CPAP or NIV and analyzing possible variables that may predict failure, namely:
lymphopenia
thrombocytopenia
CRP
ferritin
LDH
troponin I
NT-ProBNP
Liver enzymes
D-dimers
radiologic aggravation " 1 day and 1 week after starting NIV or CPAP
Other: Evaluate HACOR score effectivity in this patients
Apply the HACOR score after starting NIV and CPAP and later verify if it was effective in predicting NIV/CPAP failure
Inclusion Criteria: - Patients with acute respiratory failure due to COVID-19 who have initiated NIV or CPAP based on assistant clinician decision
Exclusion Criteria: - Patients with imediate indication to invasive mechanical ventilation - Patients with any formal contraindication to noninvasive respiratory support
Miguel Guia
00351915774975
miguelguia7@gmail.com
Antonio Esquinas
0034609321966
antmesquinas@gmail.com
Miguel Guia
Principal Investigator
Hospital General Universitario Morales Meseguer
~
Antonio Esquinas
Study Director
Hospital General Universitario Morales Meseguer